Nachrichten
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of ...
3 T.
GlobalData via MSNFormer 23andMe CEO regains company control as $305m sale to nonprofit approvedFormer 23andMe CEO Anne Wojcicki now runs TTAM Research Institute, which outbid Regeneron in an auction for the bankrupt ...
Maintaining control of the company's assets has been Wojcicki's plan since 23andMe declared bankruptcy in March 2025. She originally resigned as the company's CEO to make a bid on the company.
Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ-2.46%decrease; red down pointing triangle, is poised to regain control of the DNA-testing company after a nonprofit she controls ...
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.
Former 23andMe CEO Anne Wojcicki is set to regain control of the genetic testing firm she led to bankruptcy after outbidding a pharmaceutical company at an auction. The sale came on Monday after a ...
23andMe co-founder and former CEO Anne Wojcicki is set to buy back the company through a nonprofit public benefit corporation, TTAM Research Institute.
Nach Insolvenz kommt Wojcicki wieder ans Ruder Einige Monate nach dem Vorfall stellte 23andme Insolvenzantrag. Daher ist nicht gesichert, dass die britische Strafe in der festgesetzten Höhe ...
23andMe filed for bankruptcy in March, prompting the resignation of Wojcicki, who earlier launched a bid to take 23andMe private with a $0.40 per share offer, valuing the company at around $40 ...
23andMe analysierte Erbgut mittels Speichelprobe auf Krankheitsrisiken. Nach Insolvenz und Bietergefecht soll die Firma nun an eine Mitgründerin gehen. Kevin Gallant 17.06.2025 - 18:16 Uhr Das ...
23andmeA class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March. Cofounder and former CEO Anne Wojcicki won a bid to regain control of the company in ...
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by its former CEO Anne Wojcicki, effectively putting her back in control of the bankrupt genetics company. Regeneron ...
Ergebnisse, auf die Sie möglicherweise nicht zugreifen können, werden derzeit angezeigt.
Ergebnisse ausblenden, auf die nicht zugegriffen werden kann